Detalles de la búsqueda
1.
Efficacy and safety of immune checkpoint inhibitors in solid tumor patients combined with chronic coronary syndromes or its risk factor: a nationwide multicenter cohort study.
Cancer Immunol Immunother
; 73(8): 159, 2024 Jun 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38850359
2.
Dynamic radiological features predict pathological response after neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma.
J Transl Med
; 22(1): 471, 2024 May 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38762454
3.
VDR promotes pancreatic cancer progression in vivo by activating CCL20-mediated M2 polarization of tumor associated macrophage.
Cell Commun Signal
; 22(1): 224, 2024 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38600588
4.
China special issue on gastrointestinal tumors-Regulatory-immunoscore-A novel indicator to guide precision adjuvant chemotherapy in colorectal cancer.
Int J Cancer
; 153(11): 1904-1915, 2023 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37085990
5.
Comparison of the effectiveness of chemotherapy combined with immunotherapy and chemotherapy alone in advanced biliary tract cancer and construction of the nomogram for survival prediction based on the inflammatory index and controlling nutritional status score.
Cancer Immunol Immunother
; 72(11): 3635-3649, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37668711
6.
Heterogeneous expression of ARID1A in colorectal cancer indicates distinguish immune landscape and efficacy of immunotherapy.
Discov Oncol
; 15(1): 92, 2024 Mar 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38555560
7.
Predicting postoperative prognosis of pancreatic cancer using a computed tomography-based radio-clinical model: exploring biologic functions.
J Gastrointest Surg
; 28(4): 458-466, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38583896
8.
Colorectal medullary carcinoma: a pathological subtype with intense immune response and potential to benefit from immune checkpoint inhibitors.
Expert Rev Clin Immunol
; : 1-12, 2024 Mar 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38459764
9.
Inhibition of HDAC2 sensitises antitumour therapy by promoting NLRP3/GSDMD-mediated pyroptosis in colorectal cancer.
Clin Transl Med
; 14(6): e1692, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38804602
10.
Advances and prospects of drug clinical research in colorectal cancer in 2022.
Cancer Innov
; 2(2): 99-113, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38090057
11.
Retrospective study of the combination of TP and PF regimens with or without immune checkpoint inhibitors for the first-line treatment of locally advanced or advanced esophageal squamous cell carcinoma.
Ther Adv Med Oncol
; 15: 17588359231169981, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37188111
12.
Epigenetic-related gene mutations serve as potential biomarkers for immune checkpoint inhibitors in microsatellite-stable colorectal cancer.
Front Immunol
; 13: 1039631, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36479108
Resultados
1 -
12
de 12
1
Próxima >
>>